https://vilalab.org/research-projects/chronic-blockade-of-mitochondrial-function-and-experimental-models-of-parkinsons-disease/2026-09-23T15:48:36+00:00https://vilalab.org/research-projects/caspase-3-independent-programmed-cell-death-in-the-mptp-mouse-model-of-parkinsons-disease/2026-09-23T15:48:59+00:00https://vilalab.org/research-projects/role-of-bax-dependent-cell-death-molecular-pathways-in-the-mptp-model-of-parkinsons-disease/2026-09-23T15:49:14+00:00https://vilalab.org/research-projects/mechanisms-of-bax-activation-in-the-mptp-mouse-model-of-parkinsons-disease/2026-09-23T15:50:09+00:00https://vilalab.org/research-projects/targeting-programmed-cell-death-as-a-new-therapeutic-strategy-for-parkinsons-disease/2026-09-23T15:50:45+00:00https://vilalab.org/research-projects/role-of-mitochondrial-dysfunction-in-parkinsons-disease-neurodegeneration/2026-09-23T16:18:11+00:00https://vilalab.org/research-projects/mechanisms-and-significance-of-lewy-body-formation-in-parkinsons-disease/2026-09-23T16:17:55+00:00https://vilalab.org/research-projects/mechanisms-of-propagation-and-progression-of-parkinsons-disease-role-of-lewy-bodies/2026-09-23T16:17:33+00:00https://vilalab.org/research-projects/support-to-emerging-research-groups/2026-09-23T16:17:17+00:00https://vilalab.org/research-projects/altered-autophagy-in-huntingtons-disease/2026-09-23T16:16:57+00:00https://vilalab.org/research-projects/altered-autophagy-in-huntingtons-disease-2/2026-09-23T16:16:42+00:00https://vilalab.org/research-projects/generation-of-induced-pluripotent-stem-cells-ipsc-derived-da-neurons-from-patients-with-familial-and-sporadic-parkinsons-disease/2026-09-23T16:16:19+00:00https://vilalab.org/research-projects/innovative-solutions-to-accelerate-the-identification-and-development-of-new-drugs-for-the-treatment-of-diseases-of-the-nervous-system/2026-09-23T16:16:03+00:00https://vilalab.org/research-projects/initiation-progression-and-extension-of-parkinsons-disease-role-of-%ce%b1-synuclein-and-lewy-bodies/2026-09-23T16:15:48+00:00https://vilalab.org/research-projects/neuroprotective-strategies-and-biomarkers-in-parkinsons-disease-based-on-lysosomal-impairment/2026-09-23T16:15:31+00:00https://vilalab.org/research-projects/mitochondrial-dynamics-and-mitophagy-as-therapeutic-targets-in-parkinsons-disease-and-huntingtons-disease/2026-09-23T16:15:13+00:00https://vilalab.org/research-projects/suppression-of-alpha-synuclein-expression-and-pde10-as-a-new-therapeutic-strategy-to-parkinson-disease-and-improvement-of-cognitive-dysfunctions/2026-09-23T15:00:07+00:00https://vilalab.org/research-projects/generation-of-humanized-mouse-models-to-study-the-role-of-neuromelanin-in-parkinson-disease/2026-09-23T14:59:44+00:00https://vilalab.org/research-projects/regenerating-dopaminergic-neurons-in-parkinsons-disease-via-cell-fusion-mediated-reprogramming/2026-09-23T16:14:27+00:00https://vilalab.org/research-projects/prion-like-dissemination-of-synuclein-pathology-a-non-human-primate-study/2026-09-23T14:59:21+00:00https://vilalab.org/research-projects/mitochondrial-dysfunction-in-parkinsons-disease-role-of-mitochondrial-dynamics/2026-09-23T16:13:30+00:00https://vilalab.org/research-projects/support-to-consolidated-research-groups/2026-09-23T16:13:15+00:00https://vilalab.org/research-projects/characterization-of-a-novel-therapy-to-selectively-silence-alpha-synuclein-in-monoaminergic-neurons/2026-09-23T14:58:44+00:00https://vilalab.org/research-projects/role-of-alpha-synuclein-and-neuromelanin-in-the-initiation-and-extension-of-parkinsons-disease-therapeutic-and-diagnosis-potential-in-novel-pre-clinical-models/2026-09-23T16:12:37+00:00https://vilalab.org/research-projects/targeting-the-transcriptional-regulator-of-autophagy-lmx1b-for-parkinsons-disease-therapeutic-development/2026-09-23T16:12:15+00:00https://vilalab.org/research-projects/role-of-the-cellular-prion-protein-as-cross-talk-protein-between-alpha-syn-lrrk2-and-p-tau-in-sporadic-and-familiar-parkinsons-disease/2026-09-23T16:11:55+00:00https://vilalab.org/research-projects/transcriptional-profiling-in-prodromal-subgroups-of-parkinsons-disease/2026-09-23T16:11:40+00:00https://vilalab.org/research-projects/pathogenic-role-of-autophagic-lysosomal-dysfunction-in-parkinsons-disease-diagnosis-and-new-preclinical-therapies/2026-09-23T16:11:25+00:00https://vilalab.org/research-projects/new-therapeutic-strategies-for-the-treatment-of-synucleinopathies/2026-09-23T16:11:09+00:00https://vilalab.org/research-projects/targeting-a-novel-transcriptional-pathway-to-reduce-alpha-synuclein-expression/2026-09-23T14:49:31+00:00https://vilalab.org/research-projects/adaptive-immune-response-in-parkinsons-disease-induced-by-alpha-synuclein-proteoforms-present-in-lewy-bodies-diagnostic-and-therapeutic-application-2/2026-09-23T16:10:32+00:00https://vilalab.org/research-projects/a-precise-approach-for-nucleoside-based-therapy-of-neuromuscular-disorders-with-defects-in-mitochondrial-dna/2026-09-23T16:10:19+00:00https://vilalab.org/research-projects/support-to-consolidated-research-groups-2/2026-09-23T16:10:02+00:00https://vilalab.org/research-projects/the-gut-brain-axis-in-prodromal-parkinsons-disease-new-possibilities-for-risk-diagnostic-biomarkers-and-therapeutic-interventions/2026-09-23T16:09:48+00:00https://vilalab.org/research-projects/identification-of-pathophysiological-biomarkers-in-the-prodromal-preclinical-phase-of-parkinsons-disease/2026-09-23T16:09:34+00:00https://vilalab.org/research-projects/synuclean-d-a-novel-molecule-to-cure-parkinsons-disease/2026-09-23T16:09:21+00:00https://vilalab.org/research-projects/pathogenic-role-of-neuromelanin-in-parkinsons-disease-and-brain-aging-molecular-mechanisms-in-a-novel-humanized-pre-clinical-in-vivo-model/2026-09-23T14:48:31+00:00https://vilalab.org/research-projects/autophagic-lysosomal-dysfunction-in-parkinsons-disease-characterization-and-development-on-new-translational-strategies-to-therapeutically-target-lysosomes/2026-09-23T16:08:58+00:00https://vilalab.org/research-projects/therapeutic-target-of-gcase-enzyme-in-parkinsons-disease-with-novel-pharmacological-chaperones/2026-09-23T14:47:56+00:00https://vilalab.org/research-projects/diagnostic-therapeutic-potential-of-neuromelanin-in-parkinson-disease-using-novel-humanized-preclinical-in-vivo-mode/2026-09-23T16:05:30+00:00https://vilalab.org/research-projects/focused-ultrasound-modulation-of-neuromelanin-accumulation-in-a-humanized-rat-model-of-parkinsons-disease/2026-09-23T14:47:19+00:00https://vilalab.org/research-projects/adaptive-immune-response-in-parkinsons-disease-induced-by-patient-derived-alpha-synuclein-epitopes-development-of-neuroprotective-strategies/2026-09-23T16:05:11+00:00https://vilalab.org/research-projects/the-gut-brain-axis-in-parkinsons-disease-novel-pathogenic-mechanisms-and-new-possibilities-for-biomarkers-and-therapeutic-approaches-2/2026-09-23T16:04:54+00:00https://vilalab.org/research-projects/modulation-of-age-dependent-neuromelanin-accumulation-as-a-novel-therapeutic-strategy-for-parkinsons-disease-and-brain-aging/2026-09-23T14:46:43+00:00https://vilalab.org/research-projects/characterization-of-a-novel-neuromelanin-producing-transgenic-mouse-model-relevance-to-parkinsons-disease-and-brain-aging-2/2026-09-23T14:46:21+00:00https://vilalab.org/research-projects/development-of-new-nanotechnological-based-enzyme-replacement-therapy-for-parkinsons-disease-restoration-of-lysosomal-glucocerebrosidase-activity-through-enzyme-polymer-nanoconjugation-of-gb/2026-09-23T16:04:10+00:00https://vilalab.org/research-projects/the-vall-dhebron-iniciative-for-parkinson-associated-to-gba-vhip-gba-from-biospecimen-collection-to-translational-studies-and-therapies/2026-09-23T16:03:45+00:00https://vilalab.org/research-projects/neurodegeneration-linked-to-neuromelanin-in-parkinsons-disease-mechanistic-diagnostic-and-therapeutic-implication/2026-09-23T16:03:29+00:00https://vilalab.org/research-projects/sex-based-modulation-of-neuromelanin-linked-parkinsons-disease-pathology/2026-09-23T14:45:24+00:00https://vilalab.org/research-projects/targeting-neuromelanin-linked-neuronal-dysfunction-and-degeneration-in-ageing-and-parkinsons-disease-using-a-combined-imaging-and-brain-stimulation-approach/2026-09-23T14:45:05+00:00https://vilalab.org/research-projects/molecular-mechanisms-of-neuromelanin-linked-neurodegeneration-in-parkinsons-disease-and-brain-aging/2026-09-23T16:02:54+00:00https://vilalab.org/research-projects/targeting-programmed-cell-death-in-parkinsons-disease/2026-09-23T14:44:26+00:00https://vilalab.org/research-projects/activity-and-connectivity-drive-neuronal-vulnerability-and-disease-progression-in-parkinsons-disease/2026-09-23T14:43:46+00:00https://vilalab.org/research-projects/mapping-intranasal-nanoconjugates-for-parkinson-mri-analysis-of-cns-targeting-and-biodistribution-minn4park/2026-09-23T16:01:58+00:00https://vilalab.org/research-projects/nanonosetobrain-nanotechnology-driven-platform-for-the-delivery-of-enzymes-and-other-therapeutic-compounds-to-the-brain/2026-09-23T16:01:46+00:00https://vilalab.org/research-projects/new-nanotechnological-therapy-for-parkinsons-disease-nose-to-brain-delivery-of-gba-polymer-nanoconjugates/2026-09-23T14:42:59+00:00https://vilalab.org/research-projects/1369/2026-09-23T16:01:23+00:00https://vilalab.org/research-projects/2-divhulga-programa-anual-de-actividades-ucci-del-campus-vall-dhebron-vh-fct-23-19812/2026-09-23T16:01:11+00:00https://vilalab.org/research-projects/the-gut-brain-axis-in-parkinsons-disease-for-biomarkers-and-therapeutic-development-cns2023-145555/2026-09-23T16:00:06+00:00https://vilalab.org/research-projects/the-gut-brain-axis-in-parkinsons-disease-from-pathophysiology-to-biomarkers-and-new-therapeutic-approaches-ryc2021-032947-i/2026-09-23T16:00:30+00:00https://vilalab.org/research-projects/peripheral-synucleinopathy-pathogenicity-and-modulation-of-propagation/2026-09-23T16:00:19+00:00https://vilalab.org/research-projects/the-gut-brain-axis-in-patients-with-parkinsons-disease-from-pathophysiology-to-biomarkers-and-new-therapeutic-approaches-pi21-01603/2026-09-23T15:59:55+00:00https://vilalab.org/research-projects/avanzando-en-el-manejo-de-la-enfermedad-de-parkinson-abordando-la-disfuncion-autofagica-lisosomal-para-el-desarrollo-de-herramientas-innovadoras-de-diagnosticos-y-terapeuticas-pi24-00062/2026-09-23T15:59:43+00:00https://vilalab.org/research-projects/nanoert-nano-delivery-platform-for-enzyme-replacement-therapy-in-parkinsons-and-gauchers-disease-producte-agaur-2024/2026-09-23T15:59:26+00:00https://vilalab.org/research-projects/nanoert-nano-delivery-platform-for-enzyme-replacement-therapy-in-parkinsons-and-gauchers-disease-producte-agaur-2024-2/2026-09-23T15:59:16+00:00https://vilalab.org/research-projects/nanoert-nano-delivery-platform-for-enzyme-replacement-therapy-in-parkinsons-and-gauchers-disease/2026-09-23T15:58:57+00:00https://vilalab.org/research-projects/gba1-consortium-joint-analysis-to-inform-clinical-trials-mjff-025301/2026-09-23T14:41:36+00:00https://vilalab.org/research-projects/1-gastrointestinal-dysfunction-inflammation-and-synuclein-pathology-in-parkinsons-disease-patients-potential-for-diagnostic-and-therapeutic-development-pi24-00253/2026-09-23T15:58:35+00:00https://vilalab.org/research-projects/parkinsons-intergenerational-care-pair/2026-09-23T15:58:25+00:00https://vilalab.org/research-projects/pathogenic-interplay-between-age-dependent-neuromelanin-accumulation-and-parkinsons-disease-susceptibility-factors-role-in-the-onset-and-progression-of-the-disease-neuromelaninpd/2026-09-23T15:58:08+00:00https://vilalab.org/research-projects/neuromelanin-and-pd-mechanisms-and-therapeutic-perspectives/2026-09-16T11:15:50+00:00https://vilalab.org/research-projects/next-generation-enzyme-replacement-therapy-for-neurodegenerative-and-lysosomal-storage-diseases-2025innov-00005/2026-09-23T15:57:48+00:00https://vilalab.org/research-projects/validacio-funcional-duna-nova-terapia-intravenosa-de-reemplacament-enzimatic-per-a-malalties-lisosomals-amb-afectacio-sistemica-i-cerebral-slt041-25-000039/2026-09-23T15:57:34+00:00https://vilalab.org/research-projects/enzyme-nanoconjugates-for-advanced-enzyme-replacement-therapies-nano-ert/2026-09-23T15:57:06+00:00https://vilalab.org/research-projects/validacion-preclinica-y-transferencia-tecnologica-de-nanoconjugados-para-terapias-de-reemplazo-enzimatico-de-nueva-generacion-dirigidas-a-enfermedades-raras/2026-09-23T15:56:58+00:00https://vilalab.org/research-projects/1415/2026-09-28T09:37:14+00:00https://vilalab.org/research-projects/evaluacion-del-impacto-social-del-programa-pair-uniendo-adolescentes-y-personas-con-parkinson-cx24-00187/2026-09-23T15:56:19+00:00https://vilalab.org/research-projects/cd8-t-cells-and-infections-of-the-nervous-system-as-initiators-and-propagators-of-parkinsons-disease-towards-patient-stratification-based-on-peripheral-tissue-biopsies/2026-09-23T15:54:36+00:00https://vilalab.org/research-projects/neuromelanin-related-compounds-in-peripheral-biological-samples-as-biomarkers-for-neurodegenerative-diseases-associated-with-loss-of-pigmented-neurons/2026-09-23T16:20:29+00:00https://vilalab.org/research-projects/study-of-the-cd8-t-cell-response-and-the-antigens-involved-in-parkinsons-disease-neuronal-death-sars-cov-2-hyposmia-as-a-possible-early-cd8-t-cell-induced-stage/2026-09-28T09:44:36+00:00